Fresenius Kabi Deutschland GmbH is a leading German healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Its comprehensive product portfolio includes intravenous generic drugs, infusion therapies, clinical nutrition products, and medical devices for their administration. The company also focuses on biopharmaceuticals, including biosimilars for autoimmune diseases and oncology, serving critically and chronically ill patients.